MOODY ALDRICH PARTNERS LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,126,000
-53.5%
20,119
-39.7%
0.23%
-32.0%
Q1 2022$2,424,000
-30.9%
33,358
+12.5%
0.34%
-30.3%
Q4 2021$3,507,000
-25.3%
29,658
-15.3%
0.49%
-18.0%
Q3 2021$4,695,000
-3.9%
35,000
+15.9%
0.60%
-13.2%
Q2 2021$4,888,00030,1910.69%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders